Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
11 hedge funds and large institutions have $96.4K invested in Biocept, Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 17 closing their positions.
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
56% less funds holding
Funds holding: 25 → 11 (-14)
68% less capital invested
Capital invested by funds: $304K → $96.4K (-$208K)
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$254K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$133K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28.9K |
| 4 |
JP Morgan Chase
New York
|
+$1.52K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$17 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$66K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$45.6K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$32K |
| 4 |
HF
HRT Financial
New York
|
-$18K |
| 5 |
State Street
Boston,
Massachusetts
|
-$13.8K |
BIOC Hedge Fund Activity: Q2 2023 in Review
11 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2023, worth a combined $96.4K — down 68% from $304K a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of BIOC and 3 opened new positions — a net loss of 14 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $254K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $66K sold.
- 11 institutional investors held Biocept, Inc. (BIOC) as of Q2 2023, down from 25 in Q1 2023.
- Funds reported $96.4K of Biocept, Inc. stock for Q2 2023, down 68% quarter-over-quarter.
- 3 funds opened new Biocept, Inc. positions in Q2 2023 and 17 closed out, a net change of -14 holders.
- The largest Biocept, Inc. buyer in Q2 2023 was Anson Funds Management, an estimated $254K added.
- The largest Biocept, Inc. seller in Q2 2023 was Renaissance Technologies, an estimated $66K sold.
Based on aggregated 13F filings for Q2 2023.